Stockreport

ImmunityBio: Moving The Needle [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF Follow Play 14min Summary ImmunityBio's ANKTIVA shows promising commercial and clinical progress, with expanded patient access and potential EU/UK regulatory fi [Read more]